Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Clinical trial NCT01631214 · COMPLETED
Trial details
- NCT number
- NCT01631214
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-04
- Primary completion
- 2017-02-27
- Enrollment
- 4093
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.